These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22137785)

  • 1. Inhibitors of human 2,3-oxidosqualene cyclase (OSC) discovered by virtual screening.
    Watanabe T; Kurata I; Umezawa Y; Takahashi Y; Akamatsu Y
    Bioorg Med Chem Lett; 2012 Jan; 22(1):231-4. PubMed ID: 22137785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel pyrrole- and 1,2,3-triazole-based 2,3-oxidosqualene cyclase inhibitors.
    Watanabe T; Umezawa Y; Takahashi Y; Akamatsu Y
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5807-10. PubMed ID: 20728352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design strategies of oxidosqualene cyclase inhibitors: Targeting the sterol biosynthetic pathway.
    Rabelo VW; Romeiro NC; Abreu PA
    J Steroid Biochem Mol Biol; 2017 Jul; 171():305-317. PubMed ID: 28479228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H; Li M; Choi J; Cho H; Ham SW
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4372-5. PubMed ID: 19500977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening.
    Park H; Bahn YJ; Jeong DG; Woo EJ; Kwon JS; Ryu SE
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5372-6. PubMed ID: 18835158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.
    Park H; Bahn YJ; Ryu SE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4330-4. PubMed ID: 19497739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminopropylindenes derived from Grundmann's ketone as a novel chemotype of oxidosqualene cyclase inhibitors.
    Lange S; Keller M; Müller C; Oliaro-Bosso S; Balliano G; Bracher F
    Eur J Med Chem; 2013 May; 63():758-64. PubMed ID: 23583910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first de novo designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
    Heikkilä T; Thirumalairajan S; Davies M; Parsons MR; McConkey AG; Fishwick CW; Johnson AP
    Bioorg Med Chem Lett; 2006 Jan; 16(1):88-92. PubMed ID: 16236496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRIND-based 3D-QSAR to predict inhibitory activity for similar enzymes, OSC and SHC.
    Ermondi G; Caron G
    Eur J Med Chem; 2008 Jul; 43(7):1462-8. PubMed ID: 17981368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase.
    Galli U; Oliaro-Bosso S; Taramino S; Venegoni S; Pastore E; Tron GC; Balliano G; Viola F; Sorba G
    Bioorg Med Chem Lett; 2007 Jan; 17(1):220-4. PubMed ID: 17027267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR Biochemical Assay for Oxidosqualene Cyclase: Evaluation of Inhibitor Activities on Trypanosoma cruzi and Human Enzymes.
    Tani O; Akutsu Y; Ito S; Suzuki T; Tateishi Y; Yamaguchi T; Niimi T; Namatame I; Chiba Y; Sakashita H; Kubota T; Yanagi T; Mizukami S; Hirayama K; Furukawa K; Yamasaki K
    J Med Chem; 2018 Jun; 61(11):5047-5053. PubMed ID: 29771525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual ligand screening of α-glucosidase: Identification of a novel potent noncarbohydrate mimetic inhibitor.
    Hakamata W; Ishikawa R; Ushijima Y; Tsukagoshi T; Tamura S; Hirano T; Nishio T
    Bioorg Med Chem Lett; 2012 Jan; 22(1):62-4. PubMed ID: 22154663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidosqualene cyclase from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii and Arabidopsis thaliana expressed in yeast: a model for the development of novel antiparasitic agents.
    Balliano G; Dehmlow H; Oliaro-Bosso S; Scaldaferri M; Taramino S; Viola F; Caron G; Aebi J; Ackermann J
    Bioorg Med Chem Lett; 2009 Feb; 19(3):718-23. PubMed ID: 19119009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase.
    Thoma R; Schulz-Gasch T; D'Arcy B; Benz J; Aebi J; Dehmlow H; Hennig M; Stihle M; Ruf A
    Nature; 2004 Nov; 432(7013):118-22. PubMed ID: 15525992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylpiperidines as a new class of oxidosqualene cyclase inhibitors.
    Keller M; Wolfgardt A; Müller C; Wilcken R; Böckler FM; Oliaro-Bosso S; Ferrante T; Balliano G; Bracher F
    Eur J Med Chem; 2016 Feb; 109():13-22. PubMed ID: 26745812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovering new inhibitors of bacterial glucosamine-6P synthase (GlmS) by docking simulations.
    Floquet N; Richez C; Durand P; Maigret B; Badet B; Badet-Denisot MA
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1966-70. PubMed ID: 17291748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
    Neres J; Brewer ML; Ratier L; Botti H; Buschiazzo A; Edwards PN; Mortenson PN; Charlton MH; Alzari PM; Frasch AC; Bryce RA; Douglas KT
    Bioorg Med Chem Lett; 2009 Feb; 19(3):589-96. PubMed ID: 19144516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening.
    Cozza G; Gianoncelli A; Montopoli M; Caparrotta L; Venerando A; Meggio F; Pinna LA; Zagotto G; Moro S
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5672-5. PubMed ID: 18799313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesyloxycoumarins, a new class of squalene-hopene cyclase inhibitors.
    Cravotto G; Balliano G; Robaldo B; Oliaro-Bosso S; Chimichi S; Boccalini M
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1931-4. PubMed ID: 15050630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidosqualene cyclase inhibitors as antimicrobial agents.
    Hinshaw JC; Suh DY; Garnier P; Buckner FS; Eastman RT; Matsuda SP; Joubert BM; Coppens I; Joiner KA; Merali S; Nash TE; Prestwich GD
    J Med Chem; 2003 Sep; 46(20):4240-3. PubMed ID: 13678402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.